Lu Chen
Impact in
- Cell Biology top 5%
- Cellular transport and secretion
- Endoplasmic Reticulum Stress and Disease
- Hepatology top 10%
Papers in
- Epidemiology 18
- Hepatitis B Virus Studies 8
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- David K Banfield (3 shared papers)Linna Tu (2 shared papers)William Tai (1 shared paper)Lanman Xu (3 shared papers)Da‐Zhi Chen (3 shared papers)En-De Hu (3 shared papers)Jinlu Wu (3 shared papers)Feng‐Bin Lu (3 shared papers)
- Journals
- Hepatology (3 papers)Chemical Engineering Journal (2 papers)Molecules (2 papers)Frontiers in Cardiovascular Medicine (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lu Chen
88 papers receiving 2.0k citations
Lu Chen's Hit Papers
Peers
Comparison fields: 5 of 146
- Cell Biology 396
- Hepatology 76
- Molecular Biology 702
- Physiology 45
- Biomaterials 129
Countries citing papers authored by Lu Chen
This map shows the geographic impact of Lu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Chen more than expected).
Fields of papers citing papers by Lu Chen
This network shows the impact of papers produced by Lu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Chen. The network helps show where Lu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs Hit paper breakdown → | 2021 | 213 |
| 2 | 2008 | 191 | |
| 3 | 2019 | 131 | |
| 4 | 2018 | 111 | |
| 5 | 2018 | 80 | |
| 6 | 2012 | 50 | |
| 7 | Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue. | 1984 | 46 |
| 8 | 2015 | 45 | |
| 9 | Malignant change of juvenile polyp of colon: a case report. | 1978 | 43 |
| 10 | 2019 | 41 | |
| 11 | 2006 | 39 | |
| 12 | 2015 | 38 | |
| 13 | 2019 | 37 | |
| 14 | 2016 | 36 | |
| 15 | 2021 | 36 | |
| 16 | 2014 | 36 | |
| 17 | 2020 | 36 | |
| 18 | 2013 | 35 | |
| 19 | 2021 | 34 | |
| 20 | 2017 | 33 |
About Lu Chen
Lu Chen is a scholar working on Epidemiology, Molecular Biology, Cell Biology, Oncology and Hepatology, having authored 97 papers that have together received 2.0k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (7 papers), Hepatitis C virus research (5 papers), Endoplasmic Reticulum Stress and Disease (5 papers), Skin and Cellular Biology Research (5 papers), Menopause: Health Impacts and Treatments (4 papers), Cellular transport and secretion (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Cell Biology (396 citations), Hepatology (76 citations), Molecular Biology (702 citations), Physiology (45 citations) and Biomaterials (129 citations). Lu Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include David K Banfield, Linna Tu, William Tai, Lanman Xu, Da‐Zhi Chen, En-De Hu, Jinlu Wu, Feng‐Bin Lu, Chi Yang and Xin Chen. Their work appears in journals such as Hepatology, Chemical Engineering Journal, Molecules, Frontiers in Cardiovascular Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.